Gibson Satterwhite
Management
Well, I guess I'll answer it this way first. I think with the deals that we've been acquiring, they've been generally stabilized occupancy, so we haven't been making a big bet on stabilized occupancy. So it's really been come down to the ability to the thesis has been that given the supply-demand dynamics, that RevPOR will continue to outpace the expenses. We're seeing that play out. The top line of the core metrics notwithstanding today, I can get into that a little bit. On your question on how they are performing relative to underwriting, I think on balance, things are performing kind of in line or a little better with underwriting. If you spread that across core and on the brand new deals. The new deals are just coming in, but on the core side, we actually, in our guidance, incorporated higher than underwriting expectations. That's coming in a little better. I think on balance, everything is performing in line with expectations with underwriting. On the RevPOR side, I think as we look at kind of the underlying fundamentals in the business, I mentioned some of the drivers behind that. So, if you think about the 50 basis point decline in our outlook for the full year, pro forma year-over-year, about half of that, just slightly more than half of that, was due to the Medicaid issue in those two standalone memory care buildings. The rest of that we view as And that's something that we feel like they can overcome in terms of the portfolio with continued occupancy growth in the overall portfolio and room for margin improvement. If you look at the other piece of that, which was slightly less than half of that change, that was really due to unit mix across a little bit more IL than AL. It's buildings that have both. You're not reducing staffing levels for that. A little less acuity in memory care around the margins. Again, you're not reducing staffing levels for that. A little trend, quarterly trend to lower RevPOR memory care units. That we just didn't We feel like that'll sort itself out over time. We're not really concerned about that. We just didn't model that to bounce back in Q4. What we're seeing on the ground, the top line result, in that kind of RevPOR, us bringing RevPOR down, is not what we're seeing on the ground. What we're seeing on the ground with respect to, if you just look at like-for-like care unit type, market, our operators have been, throughout the year, been able to implement strong rate increases. As we head into next year, I think we're optimistic that we can do, that they can do the same. Kind of talking about in-place mid-single digits to high single digits of in-place rate growth. We feel like the fundamentals are really strong on that. On the expenses, labor is the bulk of your cost structure. We're not hearing a lot of acute pressure as we go into budgeting season, as people look into 2027. Generally speaking, most people are talking about kind of cost of living increases. I think we feel like the fundamentals underlying the business are strong. We feel like some of the top line around the SHOP metrics are a little bit more noise than signal.